annual current liabilities:
$39.50M+$8.38M(+26.91%)Summary
- As of today (June 26, 2025), CLDX annual total current liabilities is $39.50 million, with the most recent change of +$8.38 million (+26.91%) on December 31, 2024.
- During the last 3 years, CLDX annual current liabilities has risen by +$22.97 million (+138.99%).
- CLDX annual current liabilities is now at all-time high.
Performance
CLDX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$32.02M-$7.48M(-18.94%)Summary
- As of today (June 26, 2025), CLDX quarterly total current liabilities is $32.02 million, with the most recent change of -$7.48 million (-18.94%) on March 31, 2025.
- Over the past year, CLDX quarterly current liabilities has increased by +$5.73 million (+21.78%).
- CLDX quarterly current liabilities is now -18.94% below its all-time high of $39.50 million, reached on December 31, 2024.
Performance
CLDX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CLDX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.9% | +21.8% |
| 3 y3 years | +139.0% | +119.9% |
| 5 y5 years | +239.3% | +192.9% |
CLDX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +139.0% | -18.9% | +119.9% |
| 5 y | 5-year | at high | +239.3% | -18.9% | +195.3% |
| alltime | all time | at high | +7800.2% | -18.9% | +6303.6% |
CLDX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $32.02M(-18.9%) |
| Dec 2024 | $39.50M(+26.9%) | $39.50M(+23.1%) |
| Sep 2024 | - | $32.09M(+16.0%) |
| Jun 2024 | - | $27.66M(+5.2%) |
| Mar 2024 | - | $26.29M(-15.5%) |
| Dec 2023 | $31.13M(+67.2%) | $31.13M(+11.8%) |
| Sep 2023 | - | $27.84M(+77.9%) |
| Jun 2023 | - | $15.65M(+2.8%) |
| Mar 2023 | - | $15.22M(-18.2%) |
| Dec 2022 | $18.61M(+12.6%) | $18.61M(+14.3%) |
| Sep 2022 | - | $16.29M(-45.6%) |
| Jun 2022 | - | $29.95M(+105.7%) |
| Mar 2022 | - | $14.56M(-11.9%) |
| Dec 2021 | $16.53M(+16.3%) | $16.53M(+16.6%) |
| Sep 2021 | - | $14.18M(-2.2%) |
| Jun 2021 | - | $14.49M(-14.7%) |
| Mar 2021 | - | $16.98M(+19.5%) |
| Dec 2020 | $14.21M(+22.0%) | $14.21M(+16.4%) |
| Sep 2020 | - | $12.20M(+12.5%) |
| Jun 2020 | - | $10.84M(-0.8%) |
| Mar 2020 | - | $10.93M(-6.1%) |
| Dec 2019 | $11.64M(-7.6%) | $11.64M(-2.1%) |
| Sep 2019 | - | $11.89M(+3.3%) |
| Jun 2019 | - | $11.51M(-4.0%) |
| Mar 2019 | - | $11.99M(-4.9%) |
| Dec 2018 | $12.60M(-54.6%) | $12.60M(-25.2%) |
| Sep 2018 | - | $16.85M(-15.7%) |
| Jun 2018 | - | $19.98M(-16.8%) |
| Mar 2018 | - | $24.01M(-13.4%) |
| Dec 2017 | $27.74M(-21.3%) | $27.74M(+11.3%) |
| Sep 2017 | - | $24.91M(-13.5%) |
| Jun 2017 | - | $28.79M(+6.5%) |
| Mar 2017 | - | $27.02M(-23.3%) |
| Dec 2016 | $35.22M(+16.5%) | $35.22M(+89.1%) |
| Sep 2016 | - | $18.63M(-6.9%) |
| Jun 2016 | - | $20.00M(-21.0%) |
| Mar 2016 | - | $25.31M(-16.3%) |
| Dec 2015 | $30.24M(+23.5%) | $30.24M(+27.9%) |
| Sep 2015 | - | $23.64M(-11.4%) |
| Jun 2015 | - | $26.69M(+26.2%) |
| Mar 2015 | - | $21.15M(-13.6%) |
| Dec 2014 | $24.49M(+20.3%) | $24.49M(+13.3%) |
| Sep 2014 | - | $21.61M(+1.9%) |
| Jun 2014 | - | $21.20M(+8.7%) |
| Mar 2014 | - | $19.51M(-4.1%) |
| Dec 2013 | $20.35M(+15.1%) | $20.35M(+21.2%) |
| Sep 2013 | - | $16.80M(+34.3%) |
| Jun 2013 | - | $12.50M(-31.8%) |
| Mar 2013 | - | $18.33M(+3.6%) |
| Dec 2012 | $17.68M(+23.7%) | $17.68M(+16.9%) |
| Sep 2012 | - | $15.13M(+20.3%) |
| Jun 2012 | - | $12.58M(+0.3%) |
| Mar 2012 | - | $12.55M(-12.3%) |
| Dec 2011 | $14.30M(-29.2%) | $14.30M(+32.7%) |
| Sep 2011 | - | $10.78M(+3.5%) |
| Jun 2011 | - | $10.41M(+16.7%) |
| Mar 2011 | - | $8.92M(-55.9%) |
| Dec 2010 | $20.21M(+40.3%) | $20.21M(-13.2%) |
| Sep 2010 | - | $23.28M(-1.8%) |
| Jun 2010 | - | $23.71M(-4.5%) |
| Mar 2010 | - | $24.82M(+72.3%) |
| Dec 2009 | $14.41M(+2.2%) | $14.41M(+2.1%) |
| Sep 2009 | - | $14.11M(+9.7%) |
| Jun 2009 | - | $12.86M(-8.5%) |
| Mar 2009 | - | $14.05M(-0.3%) |
| Dec 2008 | $14.10M(+39.1%) | $14.10M(-23.5%) |
| Sep 2008 | - | $18.42M(-8.6%) |
| Jun 2008 | - | $20.16M(+75.6%) |
| Mar 2008 | - | $11.48M(+13.2%) |
| Dec 2007 | $10.14M(+0.5%) | $10.14M(+15.7%) |
| Sep 2007 | - | $8.76M(+3.5%) |
| Jun 2007 | - | $8.47M(-17.1%) |
| Mar 2007 | - | $10.21M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $10.08M(+173.1%) | $10.08M(+22.5%) |
| Sep 2006 | - | $8.23M(+24.8%) |
| Jun 2006 | - | $6.60M(+1.3%) |
| Mar 2006 | - | $6.51M(+76.4%) |
| Dec 2005 | $3.69M(-30.2%) | $3.69M(+3.0%) |
| Sep 2005 | - | $3.59M(+0.2%) |
| Jun 2005 | - | $3.58M(-22.2%) |
| Mar 2005 | - | $4.60M(-13.1%) |
| Dec 2004 | $5.29M(+56.3%) | $5.29M(+38.8%) |
| Sep 2004 | - | $3.81M(+14.5%) |
| Jun 2004 | - | $3.33M(+13.2%) |
| Mar 2004 | - | $2.94M(-13.1%) |
| Dec 2003 | $3.39M(-1.4%) | $3.39M(+6.9%) |
| Sep 2003 | - | $3.17M(-18.1%) |
| Jun 2003 | - | $3.86M(+2.0%) |
| Mar 2003 | - | $3.79M(+10.4%) |
| Dec 2002 | $3.43M(-37.8%) | $3.43M(-5.3%) |
| Sep 2002 | - | $3.62M(-29.2%) |
| Jun 2002 | - | $5.11M(+1.7%) |
| Mar 2002 | - | $5.03M(-9.0%) |
| Dec 2001 | $5.52M(+2.3%) | $5.52M(+11.3%) |
| Sep 2001 | - | $4.96M(-4.2%) |
| Jun 2001 | - | $5.18M(+29.9%) |
| Mar 2001 | - | $3.98M(-26.2%) |
| Dec 2000 | $5.40M(+145.3%) | $5.40M(+74.6%) |
| Sep 2000 | - | $3.09M(+56.2%) |
| Jun 2000 | - | $1.98M(-14.2%) |
| Mar 2000 | - | $2.31M(+4.9%) |
| Dec 1999 | $2.20M(-33.3%) | $2.20M(+10.0%) |
| Sep 1999 | - | $2.00M(-16.7%) |
| Jun 1999 | - | $2.40M(-22.6%) |
| Mar 1999 | - | $3.10M(-6.1%) |
| Dec 1998 | $3.30M(+17.9%) | $3.30M(+17.9%) |
| Sep 1998 | - | $2.80M(+47.4%) |
| Jun 1998 | - | $1.90M(-13.6%) |
| Mar 1998 | - | $2.20M(-21.4%) |
| Dec 1997 | $2.80M(+75.0%) | $2.80M(+21.7%) |
| Sep 1997 | - | $2.30M(+64.3%) |
| Jun 1997 | - | $1.40M(0.0%) |
| Mar 1997 | - | $1.40M(-12.5%) |
| Dec 1996 | $1.60M(-33.3%) | $1.60M(+45.5%) |
| Sep 1996 | - | $1.10M(-21.4%) |
| Jun 1996 | - | $1.40M(-22.2%) |
| Mar 1996 | - | $1.80M(-25.0%) |
| Dec 1995 | $2.40M(-7.7%) | $2.40M(+33.3%) |
| Sep 1995 | - | $1.80M(-14.3%) |
| Jun 1995 | - | $2.10M(-12.5%) |
| Mar 1995 | - | $2.40M(-7.7%) |
| Dec 1994 | $2.60M(-23.5%) | $2.60M(-35.0%) |
| Sep 1994 | - | $4.00M(+8.1%) |
| Jun 1994 | - | $3.70M(0.0%) |
| Mar 1994 | - | $3.70M(+8.8%) |
| Dec 1993 | $3.40M(+41.7%) | $3.40M(+17.2%) |
| Sep 1993 | - | $2.90M(+16.0%) |
| Jun 1993 | - | $2.50M(-7.4%) |
| Mar 1993 | - | $2.70M(-12.9%) |
| Dec 1992 | $2.40M(-29.4%) | - |
| Oct 1992 | - | $3.10M(-8.8%) |
| Jul 1992 | - | $3.40M(0.0%) |
| Apr 1992 | - | $3.40M(+21.4%) |
| Apr 1992 | $3.40M(+21.4%) | - |
| Jan 1992 | - | $2.80M(0.0%) |
| Oct 1991 | - | $2.80M(0.0%) |
| Jul 1991 | - | $2.80M(0.0%) |
| Apr 1991 | $2.80M(+12.0%) | $2.80M(+33.3%) |
| Jan 1991 | - | $2.10M(0.0%) |
| Oct 1990 | - | $2.10M(-32.3%) |
| Jul 1990 | - | $3.10M(+24.0%) |
| Apr 1990 | $2.50M(0.0%) | $2.50M(+31.6%) |
| Jan 1990 | - | $1.90M(-24.0%) |
| Apr 1989 | $2.50M(+92.3%) | $2.50M(+92.3%) |
| Apr 1988 | $1.30M(-23.5%) | $1.30M(-23.5%) |
| Apr 1987 | $1.70M(+240.0%) | $1.70M(+240.0%) |
| Apr 1986 | $500.00K | $500.00K |
FAQ
- What is Celldex Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Celldex Therapeutics?
- What is Celldex Therapeutics annual current liabilities year-on-year change?
- What is Celldex Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly current liabilities year-on-year change?
What is Celldex Therapeutics annual total current liabilities?
The current annual current liabilities of CLDX is $39.50M
What is the all time high annual current liabilities for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total current liabilities is $39.50M
What is Celldex Therapeutics annual current liabilities year-on-year change?
Over the past year, CLDX annual total current liabilities has changed by +$8.38M (+26.91%)
What is Celldex Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CLDX is $32.02M
What is the all time high quarterly current liabilities for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total current liabilities is $39.50M
What is Celldex Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CLDX quarterly total current liabilities has changed by +$5.73M (+21.78%)